Hosted on MSN2mon
Why Sonnet BioTherapeutics (SONN) Shares Are Down 19% TodaySonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares are trading lower by 19.9% to 72 cents Wednesday afternoon after the company announced a 1-for-8 reverse stock split. What Else ...
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback